Track topics on Twitter Track topics that are important to you
Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...
Event rates were low, but no major bleeding complications and no thromboembolic events occurred in the ablation group that had rivaroxaban maintained during the AF procedure. Heartwire from Meds...
Objective To determine the real world risk of gastrointestinal bleeding associated with the use of the novel oral anticoagulants dabigatran and rivaroxaban compared with warfarin.Design...
Read more about Trial Explores Rivaroxaban in Catheter AblationComments
Janssen Pharmaceuticals and its development partner, Bayer HealthCare, have initiated CALLISTO, a new comprehensive clinical research program for their novel oral anticoagulant, rivaroxaban, in patie...
In final guidance from the National Institute for Health and Care Excellence (NICE), it recommends Xarelto (rivaroxaban; Bayer) in combination with clopidogrel and aspirin, or with aspirin alone, as a...
(MedPage Today) -- Colchicine resolved pericarditis in a small French study of lupus patients.
(MedPage Today) -- Three vitreous hemorrhage cases seen in patients during switch to rivaroxaban.
Although colchicine has been a focus of research, debate and controversy for thousands of years, it was only approved by the United States Food and Drug Administration in 2009. Over the past decade, a...
The prescription of the oral anticoagulant rivaroxaban to prevent thromboembolic episodes associated with orthopaedic surgery has dramatically increased since it was introduced. Rivaroxaban is beeing ...
Rivaroxaban is increasingly used to treat patients with acute venous thromboembolism (VTE), a potentially life-threatening condition. Since absorption of rivaroxaban decreases from nearly 100% to 66% ...
Rivaroxaban is an anticoagulant prescribed for the management of atrial fibrillation. We describe a correlation between rivaroxaban and spontaneous vitreous hemorrhage.
A biological rhythm in platelet function is well known. Multiple electrode aggregometry (MEA) is a widely used assay to measure platelet aggregability. Rivaroxaban is a new oral anticoagulant frequent...